Unibest
← Back to patent-cliff list

CAS 2097133-31-6

Methyl 4-(4-chloro-6-methylpyrimidin-2-yl)-1-methoxycyclohexane-1-carboxylate

Codes: (XI)1024528-1-a,(XI)1024528-1-b

Application context (from source-drug indications)

Non-small cell lung cancerPralsetinibThyroid cancerPralsetinibMedullary thyroid cancerPralsetinib

Source drugs (routes using this intermediate)

DrugTierExpiry
PralsetinibTier C — Watch / trade2031

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.